Grazoprevir / Elbasvir CTAC Patient Input Group Webinar

CTAC Patient Input Group WebinarOn November 2 @ 11am PST / 1pm EST, the Canadian Treatment Action Council (CTAC) will be hosting a CTAC Patient Input Group Webinar about the exciting new hep C treatment grazoprevir / elbasvir.

The patient input survey that will follow CTAC’s grazoprevir / elbasvir webinar is different from PHCN’s patient input survey or PHCN’s loved ones / caregivers survey. Please consider filling out the PHCN survey that was created for you as well as CTAC’s survey.

Registration for the CTAC webinar is required to attend
. Click here to register or for more information about the webinar.

About the Canadian Treatment Action Council (CTAC)

CTAC is a Canadian non-governmental organization led by and for people living with HIV and HIV/HCV co-infection. Since 1996, they have been working to secure and ensure equitable, affordable, and timely access to treatment and care and support for people in Canada living with HIV and HIV/HCV co-infection.